De novo acute B cell leukemia/lymphoma with t(14;18)

Leukemia

Volumn 14, Issue 11, 2000, Pages 1960-1966

  Stamatoullas, A ^a   Buchonnet, G ^b   Lepretre, S ^a   Lenain, P ^a   Lenormand, B ^b   Duval, C ^a   Callat, M P ^b   Gaulard, P ^c   Bastard, C ^a   Tilly, H ^a  

^a CENTRE HENRI BECQUEREL   (France)

^b HÔPITAL CHARLES NICOLLE   (France)

^c HENRI MONDOR HOSPITAL   (France)

Author keywords

BCL 2; BCL 6; C MYC; Leukemia; Lymphoma; T(14; 18)

Indexed keywords

BETA 2 MICROGLOBULIN; BLEOMYCIN; CD19 ANTIGEN; CD2 ANTIGEN; CD3 ANTIGEN; CD37 ANTIGEN; CD4 ANTIGEN; CD5 ANTIGEN; CD8 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTARABINE; DNA; DOXORUBICIN; FOLINIC ACID; HLA ANTIGEN; IFOSFAMIDE; LACTATE DEHYDROGENASE; MESNA; METHOTREXATE; MITOXANTRONE; ONCOPROTEIN; PREDNISONE; PROTEIN BCL 2; PROTEIN P53; VINBLASTINE; VINDESINE;

ACUTE LEUKEMIA; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; B CELL LEUKEMIA; B CELL LYMPHOMA; B LYMPHOCYTE; BLAST CELL; BONE MARROW METASTASIS; BRAIN LYMPHOMA; CANCER COMBINATION CHEMOTHERAPY; CANCER INFILTRATION; CANCER MORTALITY; CANCER RECURRENCE; CANCER REGRESSION; CARCINOMATOUS MENINGITIS; CHROMOSOME TRANSLOCATION 14; CHROMOSOME TRANSLOCATION 18; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FOLLICULAR LYMPHOMA; GENE MUTATION; GENOTYPE; GRAFT VERSUS HOST REACTION; HUMAN; MALE; METASTASIS POTENTIAL; ONCOGENE C MYC; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; RELAPSE; TUMOR SUPPRESSOR GENE;

EID: 0033759079     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401910     Document Type: Article

References (31)

1. Distinctive chromosomal abnormalities in histologic subtypes of non-Hodgkin's lymphoma
2. Histologic progression in follicular lymphoma: A prospective study
3. Multiple recurrent genomic defects in follicular lymphoma: A possible model for cancer
4. P53 mutation is associated with progression of follicular lymphomas
5. Sequential bcl-2 and c-myc oncogene rearrangements associated with the clinical transformation of non-Hodgkin's lymphoma
6. Common ALL with pre-B-cell features showing (8;14) and (14;18) chromosome translocations
7. A 14;18 and an 8;14 chromosome translocation in a cell line derived from an acute B-cell leukemia
8. Acute lymphoblastic leukemia of Burkitt's type (L3 ALL) with 8;22 and 14;18 translocations and absent surface immunoglobulins
9. Clinical, morphologic and cytogenetic characteristics of patients with lymphoid malignancies characterized by both t(14;18) (q32;q21) and t(8;14) (q24;q32) or t(8;22) q24; q11)
10. De novo acute B-cell leukemia with translocation t (14;18): An entity with a poor prognosis
11. Translocations t (14;18) and t (8;14) with rearranged bcl-2 and c-myc in a case presenting as B-ALL (L3)
12. Simultaneous occurrence of t(14;18) and t(8;22) common acute lymphoblastic leukemia
13. C-myc translocation in de novo B-cell lineage acute leukemias with t (14;18) (cell lines Karpas 231 and 353)
14. Combination of t(14;18) and a Burkitt's type translocation in B-cell malignancies
15. A new B-cell line showing a complex translocation (8;14;18) and Bcl2 rearrangement
16. The t(14;18) in a patient with de novo acute lymphoblastic leukemia is associated with t(8;9)
17. Presence of three recurrent chromosomal rearrangements t(2;3)(p12;q37), del(8)(q24) and t(14;18) in an acute lymphoblastic leukemia
18. Concurrent activation of MYC and BCL2 in B cell non-Hodgkin lymphoma cell lines by translocation of both oncogenes to the same immunoglobulin heavy chain locus
19. TTF a gene encoding a novel small G protein fuses to the lymphoma associated LAZ3 gene by t(3;4) translocation
20. For the groupe d'Etude des Lymphomes de l'adulte. Comparison of autologous bone marrow transplantation with sequential chemotherapy for intermediate-grade and high-grade non-Hodgkin's lymphoma in first of 464 patients
21. Ifosfamide, etoposide, cytarabine and methotrexae as salvage chemotherapy in relapsed or refractory aggressive non-Hodgkin's lymphoma
22. LNH-84 regimen: A mulicenter study of intensive chemotherapy in 737 patients with aggressive malignant lymphoma
23. Translocations involving band 3q27 and lg gene regions in non-Hodgkin's lymphoma
24. Cloning of a breakpoint cluster region at band 3q27 in human non-Hodgkin's lymphoma
25. Nasal T-cell lymphoma: A clinicopathologic entity associated with peculiar phenotype and with Epstein-Barr virus
26. Efficient screening of p53 mutations by denaturating gradient gel electrophoresis in colorectal tumors
27. Activation of the c-myc oncogene in a precursor-B-cell blast crisis of follicular lymphoma, presenting as composite lymphoma
28. Evolution of B-cell malignancy: Pre-B cell leukemia resulting from MYC activation in a B-cell neoplasm with a rearranged BCL2 gene
29. Sequential bcl-2 and c-myc oncogene rearrangements associated with the clinical transformation of non-Hodgkin's lymphoma
30. MYC rearrangements in histologically progressed follicular lymphoma
31. Concurrent chromosomal alterations at 3q27, 8q24 and 18q21 in B-cell lymphomas